TABLE 3.
Summary of cases of pyoderma gangrenosum reported to date involving the auricular area
| PYODERMA GANGRENOSUM | |||||
|---|---|---|---|---|---|
| Case | Gender | Age of onset (years) | Site of first involvement | Associated disease | Treatment |
| A6 | Female | 3 | Left retroauricle, neck, lower back, foot | Microcytic and hypochromicanaemia | PSL 1mg/kg/day Dapsone 2mg/kg/day |
| B7 | Male | 3.5 | Preauricle | Neonatal asphyxia, panhypopituitarism, AIDS | Dapsone 12.5mg/day |
| C6 | Male | 4 | Right retroauricle, neck, lower back | Microcytic and hypochromicanaemia | PSL 1mg/kg/day Dapsone 2mg/kg/day |
| D8 | Female | 23 | Auricle | Ulcerative colitis | Hydrocortisone 500mg/day |
| E9 | Female | 29 | Periauricle area, cheek oral mucosa, leg | None | Dapsone 100mg/day plus mPSL 100mg/day IV plus intralesional triamcinolone 20mg/week |
| F* | Male | 43 | Retroauricle (bilateral) | None | Clofazimine 100mg/day PS 60mg/day |
| G10 | Female | 58 | Auricle (conchae) | Perirectal fistula, ulcerative colitis, sclerosing cholangitis | Cyclosporine 10mg/kg/day |
| H5 | Male | 59 | Auricle (lobe) | None | PSL 40mg/day |
| I9 | Male | 64 | Retroauricle | Perirectal fistula Myelofibrosis, diabetes | PSL 80mg/day |
| J11 | Male | 65 | Auricle (pinna) | mellitus | PSL 40mg/day |
PSL=prednisolone; PS=prednisone; mPSL=methylprednisolone; *=case reported herein